Boards track pay packages, bonus schemes, and KPIs. But are you clear on how behaviour is reinforced day to day – in the informal, often unnoticed moments that shape culture and execution? Performance is often won or lost here. Research and experience consistently show that culture does not just “happen.” It emerges when behaviours are…

November 20, 2025 Read more >

MM&K together with Business & Remuneration Consultancy firm 21st Century launches its First-Ever Africa Compensation Survey for the African Private Equity and Venture Capital Industry. This survey provides participating firms with market leading, detailed information on both the quantum and structure of pay in the African PE, VC, Infrastructure and Real Estate fund management industries. The survey collects…

November 11, 2025 Read more >

“Subcultures don’t signal misalignment, they reveal where strength and nuance already exist. Culture work should meet them there.” In private equity, culture is being recognised as a value lever, a driver of performance, resilience, and growth. But there’s always a catch: most companies don’t have one culture, they have many subcultures. Subcultures exist around teams,…

October 29, 2025 Read more >

October has been another busy month for the regulators. Having been dubbed by the Chancellor as “the boot on the neck of business” the government continues to seek to relax the burden of regulation on companies. Its message is that the government is on the side of business. Its priority is to enhance the attractiveness…

October 28, 2025 Read more >

As part of its growth agenda, the government has indicated that it wants more investment – but not just from “big institutions”.  There is a desire to get “ordinary individuals” (known as “retail” investors” in the industry parlance) more confident in making investments outside of their pension and standard savings accounts. It will be interesting…

October 27, 2025 Read more >

This Chair and Non-Executive Director Survey is unique as data is collected directly from Directors themselves, rather than from company staff or annual reports. This provides a more accurate picture of board practices and pay. The Survey covers: Directors’ fees and time commitments Board governance Board effectiveness, regulation, diversity and ESG AI Adoption, AI Governance,…

October 24, 2025 Read more >

We are pleased to announce the release of The 2025 HOLT-MM&K North American Private Equity and Venture Capital Compensation Report. This annual benchmark continues to offer one of the most authoritative views of compensation trends and practices across the PE and VC fund-management ecosystem in North America. (See the official 2025 report page for more…

October 23, 2025 Read more >

MM&K, the leading independent executive remuneration consultancy, has published its 2025 European Private Equity and Venture Capital Compensation Report, marking the 30th year of this annual study. Over the past three decades, the report has become an essential reference point for private equity and venture capital firms across Europe, providing comprehensive insights into pay structures,…

September 29, 2025 Read more >

For its 2025/26 edition of Life in the Boardroom, MM&K collected responses from Chairs and NEDs who hold a total of 435 board appointments, surveying them on their fees, their use of time, and their opinions and experiences on topics such as board governance, board effectiveness, and more. Life in the Boardroom collects responses directly…

September 26, 2025 Read more >

Private equity investors are increasingly recognising that the success of their investment thesis depends as much on culture as on operational performance. Recent discussions among PE boards and operating partners have highlighted that even the most detailed playbooks, growth targets, or process improvements can be undermined if culture and incentives are misaligned. Strategy sets the…

September 24, 2025 Read more >

As we move towards the last quarter of 2025, many commercial organisations will be reviewing their bonus plan provisions and starting to consider the likelihood of targets being met that were set at the beginning of the year. However, there will be some organisations for whom this process will occur at a later date. One…

September 21, 2025 Read more >

Amid rumours that Astrazeneca, which generates c.40% of its revenues in the USA, is considering switching its listing from London to New York and media comment on the collapse of the Government’s industrial policy, there is plenty to suggest that the London Stock Exchange is in for an uphill battle to attract new listings. Whilst…

July 24, 2025 Read more >